Interesting SP action since Dr Jay became our CEO. Almost all, if not all press releases have resulted in an immediate SP drop. It becomes obvious, at least to me that by blunting any spikes, new investors will be deterred from jumping in, and shareholders will become bewildered.
I am equally convinced that although this tactic has been fairly effective, it has not changed the growing evidence that leronlimab is proving to be a force to be reckoned with. I believe the pressure is there, waiting to break out, and with each effort to diminish the value of the stock, the pressure is building and when it becomes unassailable, the momentum will be astounding.
It will be a bad day for anyone shorting this company.